AbbVie Settles Patent Dispute Over Muscle Stimulation Tech
AbbVie has agreed to pay BTL Industries an undisclosed sum to settle patent litigation over muscle stimulation technology used for aesthetic purposes, the latter company said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article